In a research report, Nomura lowered its revenue forecasts for WUXI APPTEC (02359.HK) +0.100 (+0.345%) Short selling $4.44M; Ratio 4.672% by 5.3% and 4.9% for this year and next respectively, and its profit forecasts by 4.4% and 3.1%, taking into account geopolitical uncertainties arising from the Biosecure Act at the US House of Representatives, as well as the potential negative impact of the weak domestic financing environment on the company's outlook for new orders and existing orders.
Nomura dropped WUXI APPTEC's target price from $54.56 to $43.45 and maintained its Buy rating. The broker also recommended investors to closely monitor the latest progress of the US Biosecure Act and its related impacts.
Related NewsCICC: Re-entry Into High Div. Theme Should Wait Until Sufficient Pullback; Prefers Semiconductors/ Autos/ Medias/ Softwares/ Biotechs in Short Term
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2024-07-23 16:25.)
AAStocks Financial News
China's assets explosion and the high record global capital influx hit
Hong Kong Stocks Surge, Hang Seng Index Opens Up 543 Points
China's bailout policy triggers LVMH and Hermès to rise nearly 10%
Will policies boost confidence and the A-share market live up to expectations?
Check whenever you want
WikiStock APP